Inhibition of C1q, C3, and CR3 can save synaptic loss and cognitive dysfunction in AD model mice, further supporting complement mediated microglial phagocytosis involved in AD synaptic loss (Tang et al., 2019). Here, CRIPTO3 is linked to Alzheimer disease.